missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CASC3 Antibody, Novus Biologicals™

CASC3 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

£381.00

Specifications

Antigen CASC3
Applications Western Blot
Classification Polyclonal
Conjugate Unconjugated
Host Species Rabbit
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18260834
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP1-56306 		100 μL
£381.00
100µL
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

CASC3 Polyclonal specifically detects CASC3 in Human samples. It is validated for Western Blot.
Specifications

Specifications

CASC3
Polyclonal
Rabbit
Cancer
barentsz, Btz, cancer susceptibility candidate 3, Cancer susceptibility candidate gene 3 protein, metastatic lymph node 51, Metastatic lymph node gene 51 protein, MLN 51, MLN51BTZ, Protein barentsz, protein CASC3
CASC3
IgG
Western Blot
Unconjugated
RUO
O15234
22794
Synthetic peptides corresponding to CASC3(cancer susceptibility candidate 3) The peptide sequence was selected from the N terminal of CASC3. Peptide sequence MADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPS.
Primary
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.